Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

By sjmartinez • January 10, 2025

Wu K, Ge XX, Duan XF, Li JQ, Wang K, Chen QH, Huang ZM, Zhang WY, Wu Y, Li Q. Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resist Updat. 2024 Dec 24;79:101196. doi: 10.1016/j.drup.2024.101196. Epub ahead of print. PMID: 39787991.

Tags: breast cancer, Dephosphorylation, FOXO3a, General Internal Medicine, King Drew Med Ctr, Post Doc, Publications, TRAIL, Wip1

Implementing a Cardiology Quality Incentive Program to Improve Guideline-Directed Medical Therapy

Cho DJ, Bokhoor PI, Dermenchyan A, Brownell N, Delavin NL, Furlong S, Hoo J, Tibbe T, Chen LY, Vangala S, Waterman BA, Han M, Fonarow[...]

Takotsubo Cardiomyopathy Due to Diffuse Large B-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Kim JS, Ai A, Melamed KH. Takotsubo Cardiomyopathy Due to Diffuse Large B-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. JACC Case Rep. 2025 Jun 18;30(15):103691. doi: 10.1016/j.jaccas.2025.103691. PMID:[...]

How Participatory Research Can Inform Antiracism Approaches to Advance Kidney Health Equity

Senghor AS, Okoye G, Ford CL, Crews DC, Norris KC. How Participatory Research Can Inform Antiracism Approaches to Advance Kidney Health Equity. J Am Soc[...]